ESMO Asia Congress 2024: Event Announcement
en-GBde-DEes-ESfr-FR

ESMO Asia Congress 2024: Event Announcement

Ubicación: Singapore

Lugano, Switzerland, 27 November 2024 – The ESMO Asia Congress 2024 is the annual event dedicated to multidisciplinary oncology in the Asian region. It will feature a broad spectrum of topics in cancer research, including novel treatment modalities, in-depth discussions on the management of specific cancer types, pan-Asian trials and subgroup analyses of cutting-edge studies relevant for the patients in the area. Data will be presented and discussed by leading experts from across Asia and beyond. The congress will be held onsite in Singapore from 6-8 December, with no virtual option available.

Programme highlights

  • Subgroup analyses for evaluating recently approved standard of care therapies in urothelial carcinoma among the Asian population.

  • News Insights on unresectable hepatocellular carcinoma: from an Asian subgroup analysis of a Phase-3 trial on the first line-treatment to novel data on overall survival.

  • Asian perspectives on recent practice-changing Phase-3 trials for the treatment of anal, bladder, liver, lung, cervical and breast cancers.

  • Insights on the genetics, biology and practice differences between the West and Asia in light of the new Pan-Asian Guidelines Adaptations (PAGA) for biliary, lung and ovarian cancers.

  • Outlook on the Asian region: from cancer prevention and national screening programs to the management of patients with rare cancers, through environmental and infection-related cancers.

  • Related content: Special Sessions in collaboration with endorsing societies on Friday 6 December 16:45-18:15 SGT

  • Current perspectives on preventive oncology, including prevention of virus-induced cancers, the potential of molecular techniques for early detection and the role of AI in histo-pathology.

  • Discussions on the potential of cell and gene therapies for solid tumors, including the use of virotherapy, the future of CAR T cell and TIL therapies and the opportunities for clinical practice.

  • Insights on self-management of anxiety and depression in patients with fear of recurrence and on cognitive problems affecting functional outcomes after cancer treatment in young adults.

The results of the studies presented at the congress will be published online as a supplement to Annals of Oncology. The abstract titles can be viewed through the online programme.

Keynote Lecture

Obesity: Impact on cancer prevalence, management and outcomes - Actions to improve on prevention” by Elick A. Narayan, 6 December 2024, 09:35 - 10:00 SGT.

ESMO Patient Engagement Summit

The first edition of the ESMO Patient Engagement Summit will take place during the ESMO Asia Congress 2024. This dialogue platform will bring together the voices of patients, healthcare professionals, and industry representatives to identify the challenges and opportunities facing patients in the Asia-Pacific region. The aim is to shape impactful health policies while exploring patient engagement strategies to strengthen a collaborative decision-making approach in the multiple dimensions of cancer care, including prevention, access to diagnosis and treatments, survivorship, and patient rights.

Press accreditation

ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities and the embargo schedule for ESMO Asia Congress 2024. To apply for press accreditation, please fill out the form available here. Please be kindly informed that onsite press accreditation will not be available.

Third Parties Media registration

Third Parties Media representatives and Filming Crews not eligible as press, must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).

Further information
ESMO Press Office
press@esmo.org

Regions: Europe, Switzerland, Asia, Afghanistan, Bangladesh, Bhutan, Brunei, Cambodia, China, East Timor, Hong Kong, India, Indonesia, Japan, Kazakhstan, Kyrgyzstan, Laos, Macau, Malaysia, Maldives, Mongolia, Myanmar, Nepal, Korea, North, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, VietNam
Keywords: Health, Public Dialogue - health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of news releases posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2024 by DNN Corp Terms Of Use Privacy Statement